$GRCE

$1.81 -$0.12 (6.22%) Close

$GRCE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 21.0M shares outstanding

Who owns GRCE?

By type of holder

Institutions 18.1% Insiders 0.6% Everyone else 81.4%

Concentration Top 10 holders own 16.7%

Cerity Partners LLC 4.0% · Eversept Partners, LP 3.7%

Institutional ownership

18.1%

-2.2 pts vs last qtr

Institutional holders

-2 vs last qtr

Net shares bought

−464.3K

by institutions in Q2 2026

New / sold out

9 / 11

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Citadel Advisors LLC +251.0K
Maven Securities LTD NEW +200.0K

Biggest sellers in Q2 2026

Nantahala Capital Management, LLC SOLD OUT −728.2K
Renaissance Technologies LLC SOLD OUT −243.9K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Grace Therapeutics, Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2026

+168.9%

+28.05% a year

Each share's claim on the business

−62.8%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $5.59M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years34% Under 1 year66%

Quarterly turnover

27.3%

of institutional shares changed hands

Top 10 managers, median time held

1 quarter

Super Investors

Investment managers reporting GRCE on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
CP Cerity Partners LLC	849.1K	4.04%	Unchanged	Q4 '25	0.0%
Shares held by quarter Peak holding849.1K (Q1'26) Change over 8 quarters+849.1K Share of the company4.040% Cerity Partners LLC's full portfolio →
EP Eversept Partners, LP	772.9K	3.67%	+16.3K (+2.2%)	Q1 '26	0.1%
Shares held by quarter Peak holding772.9K (Q2'26) Change over 8 quarters+772.9K Share of the company3.670% Eversept Partners, LP's full portfolio →

Cerity Partners LLC

849.1K

% of company

4.04%

Change vs last qtr

Unchanged

Held since

Q4 '25

Eversept Partners, LP

772.9K

% of company

3.67%

Change vs last qtr

+16.3K (+2.2%)

Held since

Q1 '26

28 more super investors behind a free account

See every manager holding Grace Therapeutics, Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting GRCE on Form N-PORT; together they hold 2.2% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$909K	400.4K	1.90%	0.00%	June 30, 2026
IM iShares Micro-Cap ETF iShares Trust	$79.9K	35.2K	0.17%	0.01%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$909K

% of company

1.90%

% of the fund

0.00%

As of

June 30, 2026

iShares Micro-Cap ETF

iShares Trust

Position value

$79.9K

% of company

0.17%

% of the fund

0.01%

As of

June 30, 2026

5 more funds behind a free account

See every fund holding Grace Therapeutics, Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
KP Kohli Prashant Insider	121.4K	0.58%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.580% Kohli Prashant's insider activity →

Kohli Prashant

Insider

121.4K

% of company

0.58%

Change vs last qtr

—

Held since

—

Comments